Johnson & Johnson’s Kenvue – previously the planned New Consumer Health Company – is just one part of the 135-year ... Kenvue’s visual identity, the logo for the independent new company ...

Kenvue beat analysts' expectations for first-quarter profit and revenue on Thursday as strong demand for its cough-and-cold ...

Barclays lowered the firm’s price target on Kenvue (KVUE) to $22 from $23 and keeps an Equal Weight rating on the shares as part of a Q1 earnings preview for the consumer staples group.

Citi raised the firm’s price target on Kenvue (KVUE) to $22 from $21 and keeps a Neutral rating on the shares as part of a Q1 earnings preview for the beverages and household and personal care ...